CN Patent

CN103582643B — 蛋白激酶抑制剂

Assigned to Pharmascience Inc · Expires 2016-06-15 · 10y expired

What this patent protects

本发明涉及新的激酶抑制剂。已经发现这类化合物是有效的包括PDGFR和VEGFR家族成员的蛋白激酶的抑制剂。

USPTO Abstract

本发明涉及新的激酶抑制剂。已经发现这类化合物是有效的包括PDGFR和VEGFR家族成员的蛋白激酶的抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN103582643B
Jurisdiction
CN
Classification
—
Expires
2016-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Pharmascience Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.